Clinical trial
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
NCT00974974 is registered in ClinicalTrials.gov with Impax Laboratories, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease
- Lead sponsor
- Impax Laboratories, LLC
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2009
- Completion date
- March 31, 2011
- Enrollment
- 471 (actual)
- Sites
- 73
Conditions
As the registry lists them; a condition with its own page is linked.
parkinson's disease